Clinical Trials Browser

INDUSTRY × Androgen Antagonists × 90 days × Clear all

NCT06952803 2026-04-21

EvoPAR-PR02

Phase 3 Recruiting

Prostatic Neoplasms

NCT06661122 2026-04-20

HAYATE

Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

NCT04076059 2026-04-17

China ARCHES

Phase 3 Active not recruiting

180 enrolled 24 charts

Metastatic Hormone Sensitive Prostate Cancer

NCT02489318 2026-04-13

TITAN

Phase 3 Active not recruiting

1,052 enrolled 13 charts 1 FDA

Prostatic Neoplasms

NCT03767244 2026-04-13

PROTEUS

Phase 3 Active not recruiting

Prostatic Neoplasms

NCT04108208 2026-04-13

A Study of Apalutamide in Chinese Participants With Non Metastatic Castration Resistant Prostate Cancer (NM-CRPC)

Phase 4 Active not recruiting

75 enrolled 9 charts

Prostatic Neoplasms

NCT04191096 2026-03-20

KEYNOTE-991

Phase 3 Active not recruiting

1,251 enrolled 15 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body

NCT05884398 2026-03-12

LIBERTAS

Phase 3 Active not recruiting

Metastatic Castrate-sensitive Prostate Cancer

NCT04736199 2026-02-27

ARANOTE

Phase 3 Completed

669 enrolled 16 charts

Prostatic Neoplasms